The Patent Finder

Maintenance fees coming due

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

3 maintenance fees come due in the 12 months from Nov 22, 2026, the next on Feb 15, 2027. Unpaid by Aug 16, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 11,723,348Genetically Modified Mice Expressing Humanized CD47
In force
Fee due Feb 15, 2027
Lapses if unpaid Aug 16, 2027
 · High confidence
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.In forceFeb 15, 2027Aug 16, 2027High confidence
US 11,730,151Genetically Modified Non-Human Animals with Humanized Immunoglobulin Locus
In force
Fee due Feb 22, 2027
Lapses if unpaid Aug 23, 2027
 · High confidence
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.In forceFeb 22, 2027Aug 23, 2027High confidence
US 11,987,615Modified Immunoglobulins
In force
Fee due Nov 21, 2027
Lapses if unpaid May 22, 2028
 · High confidence
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.In forceNov 21, 2027May 22, 2028High confidence
3 of 3 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited